experi multiag chemotherapi osteosarcoma outcom clinic research author institut patient osteosarcoma effect adjuv chemotherapi year experi limb-salvag surgeri outlook patient nonmetastat high-grad osteosarcoma result single-ag adjuv postop chemotherapi trial project five-year disease-fre surviv df confid interv CI follow-up period year two-year df follow-up period year six-ag adjuv postop chemotherapi limb-salvag surgeri patient patient limb-salvag oper two-year df patient limb-salvag oper follow-up period year ampute follow-up period year patient limb-salvag oper risk relaps patient cross-bon amput administr multiag adjuv chemotherapi df patient nonmetastat high-grad osteosarcoma 